Facilities

Scouting for new leadership, prices hikes and successful acquisitions. What’s new for pharma in business?

Fail to Prepare? Prepare to Fail…

Gene finds that the pressures of viral vector manufacturing are almost too much.

By simulating processes in a digital twin of a facility, changes can be safely tested before application in the real world.

Viral contamination can have devastating effects. But innovations upstream can help prevent that.

Helping to meet demands and reduce shortages... Is continuous manufacturing the way forward for pharma?

ADCs have suffered a few setbacks over the years, but interest in their therapeutic potential – particularly against cancer – remains high.

If cell and gene therapy products are to successfully reach patients, then the industry will need more facilities capable of manufacturing them.

Eva decides to sort out her bioburden issues after a disturbing dream...

Proactive stress testing is a must to keep facilities fit and healthy.